Perfluorinated chemicals and fetal growth: A study within the Danish national birth cohort

Environmental Health Perspectives

Volumn 115, Issue 11, 2007, Pages 1677-1682

  Fei, Chunyuan ^a   McLaughlin, Joseph K ^b,c   Tarone, Robert E ^b,c   Olsen, Jorn ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Birth weight; Cord blood; Length of gestation; Low birth weight; Maternal blood; PFOA; PFOS; Preterm birth; Small for gestational age

Indexed keywords

ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANE SULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD; COHORT ANALYSIS; DENMARK; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DEVELOPMENT; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; PREGNANCY;

ADULT; ALKANESULFONIC ACIDS; BIRTH WEIGHT; COHORT STUDIES; DENMARK; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; OCTANOIC ACIDS; PREGNANCY;

EID: 38449098946     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10506     Document Type: Article

References (42)

1. Albertsen K, Andersen AM, Olsen J, Gronbaek M. 2004. Alcohol consumption during pregnancy and the risk of preterm delivery. Am J Epidemiol 159:155-161.
2. Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, et al. 2007a. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41:3891-3897.
3. Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, et al. 2007b. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115:1670-1676.
4. Betts KS. 2007. Perfluoroalkyl acids: what is the evidence telling us? Environ Sci Technol 115:A250-A256.
5. Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, et al. 2004a. Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39:363-380.
6. Butenhoff JL, Kennedy GL Jr, Frame SR, O'Connor JC, York RG. 2004b. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196:95-116.
7. Butenhoff JL, Olsen GW, Pfahles-Hutchens A. 2006. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 114:1776-1782.
8. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL. 2007. Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). Environ Sci Technol 41:2237-2242.
9. Case MT, York RG, Christian MS. 2001.Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 20:101-109.
10. Ehresman DJ, Froehlich JW, Olsen GW, Chang SC, Butenhoff JL. 2007. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ Res 103:176-184.
11. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM. 2006a. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48:759-770.
12. Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, et al. 2006b. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 48:771-779.
13. Frederiksen MC. 2001. Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol 25:120-123.
14. Glucksman P, Hanson M. 2006. Developmental Origins of Health and Disease. New York:Cambridge University Press.
15. Grasty RC, Wolf DC, Grey BE, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol 68:465-471.
16. Grice MM, Alexander BH, Hoffbeck R, Kampa DM. 2007. Self-Reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 49:722-729.
17. Henderson WM, Smith MA. 2007. Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol. Toxicol Sci 95:452-461.
18. Hinderliter PM, Mylchreest E, Gannon SA, Butenhoff JL, Kennedy GL Jr. 2005. Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211:139-148.
19. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207.
20. Jin Y, Liu X, Li T, Qin H, Zhang Y. 2004. Status of perfluorochemicals in adult serum and umbilical blood in Shenyang [in Chinese]. Wei Sheng Yan Jiu 33:481-483.
21. Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, et al. 2004. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38:4489-4495.
22. Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, et al. 2007. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 115:226-230.
23. Karrman A, Mueller JF, van Bavel B, Harden F, Toms L-ML, Lindström G. 2006. Levels of 12 perfluorinated chemicals in pooled Australian serum collected 2002-2003 in relation to age, gender and region. Environ Sci Technol 40:3742-3748.
24. Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, et al. 2004. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351-384.
25. Lau C, Butenhoff JL, Rogers JM. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198:231-241.
26. Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, et al. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90:510-518.
27. Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL. 2005a. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology; 215:126-148.
28. Luebker DJ, York RG, Moore JA, Hansen KJ, Butenhoff JL. 2005b. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: doseresponse, pharmacokinetics, and clinical chemistry. Toxicology 215:149-169.
29. Martin JW, Mabury SA, Solomon KR, Muir DC. 2003. Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 22:196-204.
30. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J.2007. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health 80:643-648.
31. Olsen GW, Burris JM, Burlew MM, Mandel JH. 2003. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45:260-270.
32. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298-1305; doi:10.1289/ehp.10009 available via http://dx.doi.org/[Online 12 June 2007].
33. Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH. 1998. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J Occup Environ Med 40:614-622.
34. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, et al. 2001. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health 29:300-307.
35. Organisation for Economic Co-operation and Development. 2002. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and Its Salts. U.S. EPA Docket AR-226-1140. Available: http://www.oecd.org/dataoecd/23/18/2382880.pdf [accessed 26 March 2007].
36. So MK, Yamashita N, Taniyasu S, Jiang Q, Giesy JP, Chen K, et al. 2006. Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China. Environ Sci Technol 40:2924-2929.
37. Swanson CA, King JC. 1983. Reduced serum zinc concentration during pregnancy. Obstet Gynecol 62:313-318.
38. Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, et al. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74:369-381.
39. Tittlemier SA, Ryan JJ, Van Oostdam J. 2004. Presence of anionic organic compounds in serum collected from northern Canadian populations. Organohalogen Compounds 66:4009-4014.
40. U.S. EPA (U.S. Environmental Protection Agency). 2006. Basic Information on PFOA. Available: http://www.epa.gov/opptintr/pfoa/pubs/pfoainfo.htm [accessed 26 March 2007].
41. Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, et al. 2007. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95:462-473.
42. Yeung LW, So MK, Jiang G, Taniyasu S, Yamashita N, Song M, et al. 2006. Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ Sci Technol 40:715-720.